Catalyst Wire Dossier Catalyst Wire Dossier

ATV/RTV+3TC

atazanavir/ritonavir + lamivudine · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATV/RTV+3TC, covering 2021-08-06 to 2021-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC [Phase 3]

See pricing